Early drug discovery is a long and costly process. New Era Pharma, LLC will provide you with comprehensive services with competitive pricing, including developing assay, screening different compound collections, identifying hit compounds, generating dose response curves, performing IC50 measurements, and determining mechanism of action.
Assay can be both enzyme- and cell-based, both in 96- or 384-well formats.
We have developed several kinase assays ready for Hight-throughput screening and hits confirmations. We are also developing several panels of ELISA assays and kits specific for Ligand-Receptor bindings.
Your Partner for Drug Discovery